financetom
Business
financetom
/
Business
/
J&J's skin disease drug meets main goal in late-stage study
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
J&J's skin disease drug meets main goal in late-stage study
May 26, 2025 5:01 AM

May 9 (Reuters) - Johnson & Johnson ( JNJ ) said on

Friday its experimental psoriasis drug met the main goal in a

late-stage study on patients 12 years and older.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
New England utility Unitil's Q3 revenue beats expectations
New England utility Unitil's Q3 revenue beats expectations
Nov 3, 2025
Overview * Unitil ( UTL ) Q3 revenue beats analyst expectations, driven by higher rates and customer growth * Adjusted EPS for Q3 beats consensus, reflecting strategic execution and customer growth * Company reports Q3 net loss, with EPS decreasing by $0.02 compared to last year Outlook * Company did not provide specific future guidance Result Drivers * HIGHER RATES...
Primoris Q3 Adjusted Earnings, Revenue Rise; Lifts 2025 Guidance
Primoris Q3 Adjusted Earnings, Revenue Rise; Lifts 2025 Guidance
Nov 3, 2025
04:54 PM EST, 11/03/2025 (MT Newswires) -- Primoris Services ( PRIM ) reported adjusted Q3 earnings late Monday of $1.88 per diluted share, up from $1.22 a year earlier. Analysts polled by FactSet expected $1.36. Revenue for the quarter ended Sept. 30 was $2.18 billion, up from $1.65 billion a year earlier. Analysts surveyed by FactSet expected $1.84 billion. The...
Palantir Technologies Beats Third-Quarter Views as US Revenue Surges
Palantir Technologies Beats Third-Quarter Views as US Revenue Surges
Nov 3, 2025
04:56 PM EST, 11/03/2025 (MT Newswires) -- Palantir Technologies ( PLTR ) late Monday reported stronger-than-expected third-quarter results as the software maker's US sales soared. Consolidated revenue climbed 63% year-on-year to $1.18 billion, exceeding Wall Street's $1.09 billion estimate. Adjusted per-share earnings totaled $0.21, topping the consensus on FactSet of $0.17. US revenue advanced 77% year over year to $883...
Douglas Dynamics Acquires the Assets of Venco Venturo Industries LLC
Douglas Dynamics Acquires the Assets of Venco Venturo Industries LLC
Nov 3, 2025
MILWAUKEE, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Douglas Dynamics, Inc. ( PLOW ) , North America’s premier manufacturer and upfitter of work truck attachments and equipment, today announced that it has completed the acquisition of substantially all the assets of Venco Venturo Industries LLC, a well-established and highly-regarded provider of truck-mounted service cranes and dump hoists. Mark Van Genderen, President...
Copyright 2023-2026 - www.financetom.com All Rights Reserved